Jim Simons Sc Pharmaceuticals Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 58,656 shares of SCPH stock, worth $198,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,656

Previous 221,000 73.46%

Holding current value

$198,843

Previous $961,000 72.22%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.12 - $5.51 $668,857 - $894,515	-162,344 Reduced 73.46%	58,656 $267,000
Q2 2024 Aug 09, 2024	SELL	$3.51 - $5.21 $52,502 - $77,931	-14,958 Reduced 6.34%	221,000 $961,000
Q1 2024 May 13, 2024	BUY	$4.86 - $6.39 $943,121 - $1.24 Million	194,058 Added 463.15%	235,958 $1.19 Million
Q4 2023 Feb 13, 2024	BUY	$4.7 - $6.63 $196,930 - $277,797	41,900 New	41,900 $263,000
Q2 2023 Aug 11, 2023	SELL	$8.94 - $11.74 $1.12 Million - $1.47 Million	-125,100 Reduced 69.12%	55,886 $569,000
Q1 2023 May 12, 2023	SELL	$5.59 - $9.47 $162,110 - $274,630	-29,000 Reduced 13.81%	180,986 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$4.02 - $7.53 $119,393 - $223,641	29,700 Added 16.47%	209,986 $1.51 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $50,624 - $73,676	-11,300 Reduced 5.9%	180,286 $1.18 Million
Q2 2022 Aug 12, 2022	BUY	$4.3 - $6.48 $23,650 - $35,640	5,500 Added 2.96%	191,586 $923,000
Q1 2022 May 13, 2022	SELL	$3.9 - $6.11 $11,310 - $17,719	-2,900 Reduced 1.53%	186,086 $1.06 Million
Q4 2021 Feb 11, 2022	SELL	$3.88 - $6.9 $17,848 - $31,740	-4,600 Reduced 2.38%	188,986 $949,000
Q3 2021 Nov 12, 2021	SELL	$4.93 - $7.15 $112,897 - $163,735	-22,900 Reduced 10.58%	193,586 $1.29 Million
Q2 2021 Aug 13, 2021	BUY	$5.19 - $7.38 $130,269 - $185,238	25,100 Added 13.11%	216,486 $1.32 Million
Q1 2021 May 13, 2021	SELL	$5.65 - $7.66 $314,705 - $426,662	-55,700 Reduced 22.54%	191,386 $1.27 Million
Q4 2020 Feb 10, 2021	SELL	$5.17 - $9.41 $263,633 - $479,844	-50,993 Reduced 17.11%	247,086 $1.31 Million
Q3 2020 Nov 13, 2020	SELL	$7.12 - $8.86 $253,521 - $315,478	-35,607 Reduced 10.67%	298,079 $2.22 Million
Q2 2020 Aug 13, 2020	BUY	$7.01 - $10.96 $989,812 - $1.55 Million	141,200 Added 73.36%	333,686 $2.46 Million
Q1 2020 May 14, 2020	BUY	$5.4 - $10.45 $155,568 - $301,054	28,809 Added 17.6%	192,486 $1.42 Million
Q4 2019 Feb 13, 2020	BUY	$4.1 - $6.21 $211,338 - $320,100	51,546 Added 45.97%	163,677 $926,000
Q3 2019 Nov 13, 2019	BUY	$3.24 - $7.35 $215,884 - $489,737	66,631 Added 146.44%	112,131 $658,000
Q2 2019 Aug 12, 2019	BUY	$2.48 - $3.76 $112,840 - $171,080	45,500 New	45,500 $145,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account